Common cold coronaviruses may offer pre-existing immunity to COVID-19

Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.

Graphite founder takes drug to recently-launched Kamau Therapeutics for a second chance: #ASH23

SAN DIEGO — After Graphite Bio’s implosion, Matthew Porteus wants to do things differently. The Stanford researcher’s stint at the biotech ended with Graphite selling

December 12, 2023

Fauci’s Hopes for D.C.: Be Prepared and Stick to the Evidence

In this exclusive video interview, Jeremy Faust, MD, editor-in-chief of MedPage Today, talks to Anthony Fauci, MD, former director of the National Institute of Allergy

July 26, 2024

Meet this year’s Endpoints 11; J&J winds down cardiovascular and metabolic unit; BMS wins schizophrenia approval; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.